About 30 results found for searched term "Vasopressin Receptor" (0.26 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1917 | Mozavaptan | Vasopressin Receptor |
| OPC-31260 | ||
| Mozavaptan (OPC-31260) is a selective vasopressin V2 receptor antagonist. | ||
| M3480 | Tolvaptan | Vasopressin Receptor |
| OPC-41061 | ||
| Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. | ||
| M5166 | Conivaptan hydrochloride | Vasopressin Receptor |
| Conivaptan HCl, Vaprisol, YM 087 | ||
| Conivaptan hydrochloride is a non-peptide vasopressin receptor antagonist, which can inhibit V1A receptor in rat liver and V2 receptor in kidney with Ki values of 0.48 and 3.04 nM, respectively. | ||
| M5431 | Atosiban Acetate | Vasopressin Receptor |
| RW22164 acetate; RWJ22164 acetate | ||
| Atosiban (RW22164; Tractocile) Acetate is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. | ||
| M7356 | TASP 0390325 | Vasopressin Receptor |
| TASP0390325 hcl | ||
| TASP0390325 is a potent and orally active arginine vasopressin receptor 1B (V1B receptor) antagonist with antidepressant and anxiolytic activities in rodents. | ||
| M8178 | SR 49059 | Vasopressin Receptor |
| SR49059 | ||
| SR 49059 is a potent and selective Arginine Vasopressin (AVP) V1a-receptor antagonist, with a Ki vaule of 1.4 nM. | ||
| M11393 | RG7713 | Vasopressin Receptor |
| RO5028442 | ||
| RG7713 (RO5028442) is a highly effective and selective brain-osmotic vasopressin 1A (V1a) receptor antagonist with Ki values of 1 nM (hV1a) and 39 nM (mV1a). | ||
| M10312 | Argipressin Acetate | Vasopressin Receptor |
| Arg8-vasopressin acetate, AVP | ||
| Argipressin (Arg8-vasopressin) binds to vascular arginine vasopressin receptors V1, V2 and V3, and its Kd value against V1 in A7r5 rat aortic smooth muscle cells is 1.31 nM. | ||
| M11395 | Lixivaptan | Vasopressin Receptor |
| VPA-985; WAY-VPA 985 | ||
| Lixivaptan (VPA-985, WAY-VPA 985) is an orally active, selective vasopressin receptor V2 antagonist with IC50 values of 1.2 nM in humans and 2.3 nM in rats. | ||
| M11396 | Terlipressin diacetate | Vasopressin Receptor |
| Terlipressin diacetate is a vasopressin analogue and a highly selective vasopressin V1 receptor agonist that reduces visceral blood flow and portal vein pressure and controls acute varicose rupture bleeding. Terlipressin diacetate has anti-inflammatory and antioxidant effects and can be used to study hepatorenal syndrome and norepinephrine-resistant septic shock. | ||
| M11397 | D[LEU4,LYS8]-VP TFA | Vasopressin Receptor |
| D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptors, with Ki values of 0.16 nM, 0.52 nM and 1.38 nM for rat, human and mouse V1b receptors, respectively. D[LEU4,LYS8]-VP TFA showed weak antidiuretic, vasopressor and oxytocin activity in vitro. | ||
| M11398 | Vasopressin | Metabolite/Endogenous Metabolite |
| Vasopressin is a cyclic nine-peptide synthesized in the hypothalamus center. Vasopressin participates in the hypothalamic-pituitary-adrenal axis and regulates pituitary corticotropin secretion by enhancing the stimulating effect of corticotropin-releasing factor. Vasopressin can also act as a neurotransmitter, acting by binding to specific G-protein-coupled receptors. | ||
| M14067 | Argipressin | Vasopressin Receptor |
| Arg8-vasopressin; AVP | ||
| Argipressin (Arg8-vasopressin) binds to the V1, V2, V3-vascular arginine vasopressin receptor, with a Kd value of 1.31 nM in A7r5 rat aortic smooth muscle cells for V1. | ||
| M21942 | Balovaptan | Vasopressin Receptor |
| RG7314 | ||
| Balovaptan (RG7314) is an orally available, selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist, with Kis of 1 and 39 nM for human (hV1a) and mouse (mV1a) receptors. | ||
| M25409 | Satavaptan | Vasopressin Receptor |
| SR121463 | ||
| Satavaptan (SR 121463) is a vasopressin V2 receptor antagonist. Satavaptan improves the control of ascites in cirrhosis. | ||
| M25410 | Nelivaptan | Vasopressin Receptor |
| SSR-149415 | ||
| Nelivaptan (SSR-149415) is a vasopressin V1b receptor antagonist. | ||
| M30147 | TC OT 39 | Oxytocin Receptor |
| TC OT 39 is a synthetic oxytocin analog, as well as a selective agonist of oxytocin receptor (OXTR, EC50=180 nM). TC OT 39 is also an Avprla vasopressin receptor antagonist with an Ki value of 330 nM. TC OT 39 exhibits sedative effects in mouse models. | ||
| M30218 | SRX246 | Vasopressin Receptor |
| SRX246 is a potent, CNS-penetrant, highly selective, orally bioavailable vasopressin 1a (V1a) receptor antagonist (Ki=0.3 nM for human V1a). SRX246 has no interaction at V1b and V2 receptors. SRX246 also displays negligible binding at 64 others receptors classes, including 35 G-proteincoupled receptors. SRX246 can be used for treatment of stress-related disorders. | ||
| M30785 | Selepressin | Vasopressin Receptor |
| FE 202158 | ||
| Selepressin (FE 202158) is a selective vasopressin V1A receptor agonist. Selepressin is a potent vasopressor. Selepressin can be used in the research of septic shock. | ||
| M30861 | Atosiban | Oxytocin Receptor |
| RW22164; RWJ22164 | ||
| Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research. | ||
| M31042 | Selepressin acetate | Vasopressin Receptor |
| FE 202158 acetate | ||
| Selepressin (FE 202158) acetate is a selective vasopressin V1A receptor agonist. Selepressin is a potent vasopressor. Selepressin can be used in the research of septic shock. | ||
| M41952 | Invopressin | Vasopressin Receptor |
| Invopressin is a vasopressin V1A receptor partial agonist (EC50: 1.0 nM). | ||
| M51539 | Conopressin S | Others |
| Conopressin S, isolated from Conus striatus, shows high affinity with vasopressin V1b receptor (AVPR1B), with a Ki of 8.3 nM. | ||
| M52865 | Val9-Oxytocin | Vasopressin Receptor |
| Val9-Oxytocin is a full antagonist of vasopressin (V1a) receptor. | ||
| M52867 | Dp[Tyr(methyl)2, Arg8]-Vasopressin | Vasopressin Receptor |
| Dp[Tyr(methyl)2,Arg8]-Vasopressin is a non-selective peptide arginine vasopressin Vlb receptor antagonist. | ||
| M52869 | (Phenylac1, D-Tyr(Et)2, Lys6, Arg8, des-Gly9)-Vasopressin | Vasopressin Receptor |
| (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin is a potent vasopressin V1 receptor (VP V1R) antagonist. | ||
| M52870 | Desamino(D-3-(3′-pyridyl)-Ala2, Arg8)-Vasopressin | Vasopressin Receptor |
| Desamino(D-3-(3′-pyridyl)-Ala2,Arg8)-Vasopressin, a synthetic analog of vasopressin (AVP), is a weak agonist at antidiuretic receptor. | ||
| M52871 | (d(CH2)51, Tyr(Me)2, Dab5, Arg8)-Vasopressin | Vasopressin Receptor |
| (d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin (d(CH2)5[Tyr(Me)2, Dab5]AVP) is a specific antagonist of vasopressin V1a receptor, with a pA2 of 6.71. | ||
| M52875 | (D-Arg8)-Inotocin | Vasopressin Receptor |
| (D-Arg8)-Inotocin is a potent, selective and competitive antagonist of vasopressin receptor (V1aR), with a Ki of 1.3 nM. | ||
| M52876 | D[LEU4, LYS8]-VP | Vasopressin Receptor |
| D[LEU4,LYS8]-VP is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
